deltatrials
Terminated PHASE3 INTERVENTIONAL 3-arm NCT04650893

The Effect of IV NSAID's and Corticosteroids on Dysphasia and Dysphonia Following ASDF

The Effect of Intravenous Non-steroidal Anti-inflammatory Drugs and Intravenous Corticosteroids on the Likelihood of Dysphagia and Dysphonia Following Anterior Cervical Discectomy and Fusion

Sponsor: University of Nebraska

Updated 7 times since 2021 Last updated: Aug 20, 2024 Started: Jan 2, 2021 Primary completion: Dec 8, 2023 Completion: Dec 8, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Poor compliance with data collection - too many intervals.

Listed as NCT04650893, this PHASE3 trial focuses on Dysphagia and Dysphonia and remains terminated or withdrawn. Sponsored by University of Nebraska, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2021 – ~Jan 2023 · 24 months · monthly snapshotNot Yet Recruiting~Jan 2023 – ~Jun 2023 · 5 months · monthly snapshot~Jun 2023 – ~Aug 2023 · 2 months · monthly snapshot~Aug 2023 – ~Nov 2023 · 3 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

    Status: RecruitingTerminated

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  3. Nov 2023 — Jul 2024 [monthly]

    Recruiting PHASE3

  4. Aug 2023 — Nov 2023 [monthly]

    Recruiting PHASE3

  5. Jun 2023 — Aug 2023 [monthly]

    Recruiting PHASE3

Show 2 earlier versions
  1. Jan 2023 — Jun 2023 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  2. Jan 2021 — Jan 2023 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Nebraska
Data source: University of Nebraska

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations